Impact of the J Project on progress of primary immunodeficiency care in Ukraine

Alla Volokha1, Anastasia Bondarenko1, Liudmyla Chernyshova1

  • 1Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.

Insights

The J Project enhanced primary immunodeficiency disorder (PID) diagnosis and treatment in Ukraine through European collaboration. This initiative improved early detection, genetic diagnosis, and regional research participation.

Area of Science:

  • Immunology
  • Medical Education
  • Clinical Research

Background:

  • The J Project is a collaborative European program focused on physician education and clinical research.
  • Primary Immunodeficiency Disorders (PIDs) require specialized diagnosis and care.
  • Ukraine joined the J Project early, integrating into the European PID community.

Purpose of the Study:

  • To assess the impact of the J Project on PID diagnosis and care in Ukraine.
  • To foster collaboration and knowledge exchange within the European PID network.
  • To promote the development of regional PID centers and research initiatives.

Main Methods:

  • Ukraine has hosted annual J Project meetings since 2004, expanding regional involvement.
  • The program facilitated cooperation with European colleagues from Poland, Hungary, and Belarus.
  • Assistance was provided for genetic diagnosis to identify and study PID features.

Main Results:

  • Significant improvements in early PID diagnosis in Ukraine.
  • Enhanced patient identification and treatment arrangement.
  • Advancements in understanding PID features and management approaches through genetic diagnosis.
  • Stimulated development of regional PID centers and research participation.

Conclusions:

  • The J Project has demonstrably improved PID diagnosis and management in Ukraine.
  • European collaboration is crucial for advancing PID care and research.
  • The program has fostered regional expertise and scientific engagement in Ukraine.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
511
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.6K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
107
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
241
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K